Expert Opinion on Drug Metabolism and Toxicology
短名 | Expert. Opin. Drug. Metab. Toxicol. |
Journal Impact | 3.82 |
国际分区 | TOXICOLOGY(Q1) |
期刊索引 | SCI Q1中科院 3 区 |
ISSN | 1742-5255, 1744-7607 |
h-index | 100 |
国内分区 | 医学(3区)医学药学(2区)医学毒理学(2区)医学生化与分子生物学(3区) |
Expert Opinion on Drug Metabolism & Toxicology (ISSN 1742-5255 [print], 1744-7607 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on all aspects of ADME-Tox. Each article is structured to incorporate the author’s own expert opinion on the scope for future development. The Editors welcome: Reviews covering metabolic, pharmacokinetic and toxicological issues relating to specific drugs, drug-drug interactions, drug classes or their use in specific populations; issues relating to enzymes involved in the metabolism, disposition and excretion of drugs; techniques involved in the study of drug metabolism and toxicology; novel technologies for obtaining ADME-Tox data. Drug Evaluations reviewing the clinical, toxicological and pharmacokinetic data on a particular drug. The audience consists of scientists and managers in the pharmaceutical industry, pharmacologists, clinical toxicologists and related professionals.
期刊主页投稿网址涉及主题 | 医学生物内科学药理学化学遗传学生物化学心理学生物信息学精神科药品内分泌学有机化学药代动力学病理基因物理重症监护医学核磁共振酶 |
出版信息 | 出版商: Taylor and Francis Ltd.,出版周期: Bimonthly,期刊类型: journal |
基本数据 | 创刊年份: 2005,原创研究文献占比: 12.90%,自引率:2.60%, Gold OA占比: 16.28% |
平均审稿周期 | 网友分享经验:偏慢,4-8周 |
平均录用比例 | 网友分享经验:较易 |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Assessing the therapeutic and toxicological profile of novel GLP-1 receptor agonists for type 2 diabetes
2024-9-13
Clinical pharmacokinetics of glipizide: a systematic review
2024-9-12
Intraocular drugs: pharmacokinetic strategies and the influence on efficacy and durability
2024-9-11
A pharmacokinetic and pharmacodynamic evaluation of asundexian: a novel factor XIa inhibitor for stroke prevention
2024-9-11
Drug interactions in cardiology: focus on statins and their combination with other lipid-lowering drugs
2024-9-9
<i>In vitro</i> neurotoxicity testing: lessons from chemotherapy-induced peripheral neurotoxicity
2024-9-9
Pharmacokinetics of S1P receptor modulators in the treatment of ulcerative colitis
2024-9-9
Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata
2024-9-9
Clinical pharmacokinetics and pharmacodynamics of Nicardipine; a systematic review.
2024-9-9
Pharmacokinetics and pharmacodynamics of angiogenesis inhibitors used to treat cervical cancer: current and future
2024-9-9
Analysis of drug-drug interactions in patients with HIV and metabolic syndrome
2024-9-4
Underlying mechanisms and management strategies for regorafenib-induced toxicity in hepatocellular carcinoma
2024-9-3
Milvexian a novel factor XIa inhibitor for stroke prevention: pharmacokinetic and pharmacodynamic evaluation
2024-8-30
Cardiometabolic complications in children and adolescents with HIV on antiretroviral therapy
2024-8-30
Analgesic medication considerations for chronic pain management post-bariatric surgery
2024-8-28
Safety of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease
2024-8-27
Development and application of a population pharmacokinetic model repository for caffeine dose tailoring in preterm infants
2024-8-21
Physiologically based pharmacokinetic modeling in obesity: applications and challenges
2024-8-12
Clinical pharmacokinetics of cefpodoxime: a systematic review
2024-8-9
Pharmacokinetics of aspirin: evaluating shortcomings in the literature
2024-8-2
Dose optimization of β-lactam antibiotics in children: from population pharmacokinetics to individualized therapy
2024-8-1
Population pharmacokinetics of olanzapine in pediatric patients with psychiatric disorders
2024-7-23
Population toxicokinetics of carbamazepine and its metabolite carbamazepine-10,11-epoxide in adults
2024-7-18
An update on oral antiplatelet drug interactions with proton pump inhibitors: what are the risks?
2024-7-15
Machine learning and deep learning approaches for enhanced prediction of hERG blockade: a comprehensive QSAR modeling study
2024-7-10
How can we better address the pharmacokinetics of antipsychotics in children and adolescents?
2024-7-9
Recent progress in adverse events of carboxylic acid non-steroidal anti-inflammatory drugs (CBA-NSAIDs) and their association with the metabolism: the consequences on mitochondrial dysfunction and oxidative stress, and prevention with natural plant extracts
2024-7-9
Proposing a novel approach for the long-term use of monthly paliperidone palmitate: adjusting injection dose versus adjusting injection interval
2024-7-9
Overview of preclinical and clinical studies investigating pharmacokinetics and drug–drug interactions of padsevonil
2024-7-9
Pharmacokinetic evaluation of ibrexafungerp for the treatment of vulvovaginal candidiasis and beyond
2024-7-3
Investigating in VigiBase® over 6000 cases of pneumonia in clozapine-treated patients in the context of the literature: focus on high lethality and the association with aspiration pneumonia
2024-7-2
Screening tools to evaluate the neurotoxic potential of botanicals: building a strategy to assess safety
2024-7-2
Pharmacokinetic review of janus kinase inhibitors and its clinical implications for the management of rheumatoid arthritis
2024-6-25
Bioengineered human gut-on-a-chip for advancing non-clinical pharmaco-toxicology
2024-6-24
Investigative analysis of blood-brain barrier penetrating potential of electronic nicotine delivery systems (e-cigarettes) chemicals using predictive computational models
2024-6-17
An update on microfluidic multi-organ-on-a-chip systems for reproducing drug pharmacokinetics: the current state-of-the-art
2024-6-2
Pharmacokinetics, pharmacodynamics, safety, and tolerability of dopamine-receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting
2024-6-2
Recent advances in cell-based in vitro models for predicting drug permeability across brain, intestinal, and pulmonary barriers
2024-6-2
Understanding the impact of ABCG2 Polymorphisms on Drug Pharmacokinetics:Focus on rosuvastatin and allopurinol
2024-5-29
Genetic polymorphisms of drug-metabolizing enzymes in older and Newer Anti-Seizure Medications
2024-5-29
Recent progress in machine learning approaches for predicting carcinogenicity in drug development
2024-5-27
New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): pharmacokinetics, drug-drug interactions (DDIs), and clinical impact
2024-5-22
The role of the circadian timing system on drug metabolism and detoxification: an update
2024-5-20
Pharmacokinetic evaluation of Donanemab for the treatment of Alzheimer’s
2024-5-18
Pharmacokinetic and toxicological considerations affecting antiretroviral drug dosing in pregnant women
2024-5-14
Induction effect of antiretroviral bictegravir on the expression of Abcb1, Abcg2 and Abcc1 genes associated with P-gp, Bcrp and Mrp1 transporters present in rat peripheral blood mononuclear cells
2024-5-13
New approach methods on the bench side to accelerate clinical trials during pregnancy
2024-5-13
In NAMs we trust – an innovative paradigm-shift in risk-based chemicals management for globally harmonized protection goals
2024-5-9
Regulation of carboxylesterases and its impact on pharmacokinetics and pharmacodynamics: an up-to-date review
2024-5-6
Cephalosporins with warfarin increase the risk of bleeding: myth or fact?
2024-5-3
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远